Clinical trial
A Real World Study on Local Infiltration of Bupivacaine Liposome Injection for Acute Postoperative Pain After Pediatric Orthopedic Surgery
NCT06344091 is registered in ClinicalTrials.gov with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Real World Study on Local Infiltration of Bupivacaine Liposome Injection for Acute Postoperative Pain After Pediatric Orthopedic Surgery
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- May 21, 2024
- Completion date
- May 31, 2027
- Enrollment
- 232 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
local analgesia via infiltration